Inflammatory Responses in Embryonal Cardiomyocytes Exposed to LPS Challenge. An In Vitro Model of Deciphering the Effects of LPS on the Heart

Author(s): Maria Antonietta Panaro, Angela Acquafredda, Pasqua Cavallo, Antonia Cianciulli, Concetta Saponaro, Vincenzo Mitolo

Journal Name: Current Pharmaceutical Design

Volume 16 , Issue 7 , 2010

Become EABM
Become Reviewer
Call for Editor


This study is focused on the links between the major products of inflammation and cell damage induced by the administration of lipopolysaccharide (LPS) from Salmonella typhimurium in embryonal cardiomyocytes. LPS treatment for 72 hours induced transcription factor NF-κB activation, inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 expression, nitric oxide (NO) and tumor necrosis factor (TNF)-α release. Moreover, LPS administration induced a significant cell loss, reversed by the NO-synthases inhibitor, suggesting a relationship between cell damage and iNOS-dependent NO overproduction. Cell death was reversed by the specific NF-κB inhibitor, TPCK, whereas COX-2 specific inhibitor determined an increase of cell damage in terms of apoptosis, as observed by YO-PRO immunostaining, DNA laddering analysis and caspase-3 activation. Overall these findings evidenced a selective role for NF-κB in mediating NO-induced cell damage and a protective action by COX-2 in LPS-treated embryonal cardiomyocytes. The reflection of these experiments on human cardiac pathology will be discussed.

Keywords: LPS, chick embryo, cardiomyocyte, NF-κB, nitric oxide, COX-2, apoptosis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [754 - 765]
Pages: 12
DOI: 10.2174/138161210790883516
Price: $65

Article Metrics

PDF: 9